We are happy to welcome Peter Olofsson-Sahl to the Iscaff team! Peter has extensive experience both as researcher and entrepreneur, and from management of large development projects. From May [...]
Here, we show for the first time that patient-derived xenografts may be used to generate scaffolds enabling analysis of rare tumor types, such as myxoid liposarcoma. We characterized the [...]
In this top publication in a prestigious high impact journal, the composition and presence of imprinted proteins in the breast cancer microenvironment and its potential associations with clinical [...]
In this important publication, PDSs from 78 breast cancer samples with known patient outcomes, were prepared and repopulated with donor breast cancer cell lines, followed by treatment with [...]
In this article, a novel cancer stem cell activating mechanism was described, mediated by progranulin and IL-6 secretion through activation of the receptor sortilin. Significant correlations were [...]